Promethium Advisors »

Bristol Myers Squibb shares owned by Promethium Advisors

Quarter-by-quarter ownership of Bristol Myers Squibb (BMY) shares owned by Promethium Advisors from 13F filings

Historical chart of Promethium Advisors investment in Bristol Myers Squibb

Tip: Access up to 7 years of quarterly data

All positions including Bristol Myers Squibb held by Promethium Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bristol Myers Squibb by Promethium Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.6M 70k 51.74

More positions owned by Promethium Advisors

Apple (AAPL)
Thomson Reuters Corp. (TRI)
Pfizer (PFE)
Bristol Myers Squibb (BMY)
Broadstone Net Lease (BNL)
T. Rowe Price (TROW)
Texas Pacific Land Corp (TPL)
Alphabet Cap Stk Cl A (GOOGL)
Danaher Corporation (DHR)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Cme (CME)
Ishares Tr U.s. Tech Etf (IYW)
Johnson & Johnson (JNJ)
Spdr Ser Tr Bloomberg 3-12 M (BILS)

View all positions for Promethium Advisors

Top funds holding Bristol Myers Squibb

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Charles Schwab Investment Management
Geode Capital Management
Capital Research and Management Company - Division 3
Morgan Stanley
PRIMECAP Management Company
Bank of New York Mellon
Northern Trust
T. Rowe Price Associates
Citadel Advisors
Goldman Sachs Group

View all funds holding Bristol Myers Squibb